A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition
Qiu-Yun Luo, Su-Na Zhou, Wentao Pan, Jian Sun, Liqiong Yang, Lin Zhang, Miao‐Zhen Qiu, Dajun Yang
Topics & Concepts
IbrutinibCancer researchMAPK/ERK pathwayProtein kinase BKinaseCancerPharmacologyMedicineChemistryLeukemiaInternal medicineSignal transductionChronic lymphocytic leukemiaBiochemistryChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsPancreatic and Hepatic Oncology Research